The Managing Director of Fidson Healthcare Plc, Dr. Fidelis Ayebae, has joined other stakeholders in the health sector and the capital market in urging healthcare and pharmaceutical companies in Nigeria to embrace the idea of listing on the Nigeria Stock Exchange in order to grow their businesses.
Dr. Ayebae made this remark when he addressed guests at the Nigerian Stock Exchange CEOs’ Dinner for Health sector held in Lagos.
While emphasizing the benefits of companies listing on the NSE, he said it is a planned, deliberate and strategic decision companies must make if they must expand their business.
He went ahead to make a 10-point case, highlighting the benefits of listing on the Exchange.
Some of the benefits highlighted by the Fidson boss are business survival, potential capital growth, brand visibility, wealth creation, ownership diversification, structural sustainability through corporate governance, industry rating, free media mention as well as business expansion through investors’ participation.
The NSE-CEO Dinner provided a platform for listed companies, prospects, regulators and government to collaborate and determine strategies to stimulate sustainable growth in key sectors of the national economy.
Themed: “Tapping the Opportunities in the Capital Markets for the Development of the Health Sector,” the event, which was well attended by Chief Executives of Nigerian pharmaceutical companies, heads of medical institutions, doctors and other key players in the health sector, focused on the roadmap to improving health services in Nigeria.